CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 76,393	$ 78,708
Research and development incentive receivable	646	917
Prepaid expenses and other current assets	3,661	3,682
Total current assets	80,700	83,307
Property and equipment, net	1,632	1,237
Goodwill	27,109	27,109
Right-of-use assets	9,071	7,960
Other assets	2,005	3,258
Total assets	120,517	122,871
Current liabilities:
Accounts payable	2,424	3,144
Accrued expenses	9,074	8,018
Current portion of lease liability	1,041	786
Current portion of long-term debt	693	0
Total current liabilities	13,232	11,948
Long-term debt, net of discount and current portion	33,043	33,178
Lease liabilities	5,067	4,484
Other liabilities	496	462
Total liabilities	51,838	50,072
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 125,000,000 shares authorized as of each of September 30, 2021 and December 31, 2020; 24,708,727 and 16,305,731 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	25	16
Additional paid-in capital	321,437	267,077
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(252,664)	(194,175)
Total stockholders’ equity	68,679	72,799
Total liabilities and stockholders’ equity	$ 120,517	$ 122,871